14.3 C
New York
Tuesday, March 21, 2023

An Evaluation Of Medtronic plc (NYSE: MDT) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Medtronic plc (MDT) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 0.03%, to $78.02. The Medtronic plc has recorded 132,966 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

MDT belongs to the Healthcare sector of the NYSE while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $78.00 and fluctuated between $79.33 as its day high and $77.98 as its day low. The current market capitalization of Medtronic plc is $102.34B. A total of 5.63 million shares were traded on the day, compared to an average of 6.75M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, MDT has seen 2 BUY and 2 SELL insider trades, representing the acquisition of 16,631 and the disposition of 17,303 shares. Over the last 12 months, there were 22 BUYs and 26 SELLs from insiders. Insiders purchased 125,589 shares during that period but sold 123,200.

In the most recent transaction, Medtronic plc bought 6,835 shares of MDT for 9.28 per share on Jan 30. After the transaction, the 10% Owner now owns 4,999,423 company shares. In a previous transaction on Dec 13, Salmon Sean sold 16,631 shares at 80.50 per share. MDT shares that EVP & President Cardiovascular owns now total 36,088.

Among the insiders who sold shares, TEN HOEDT ROB disposed of 2,404 shares on Oct 14 at a per-share price of $81.54. This resulted in the EVP and Pres. Global Regions holding 43,483 shares of MDT after the transaction. In another insider transaction, PARKHILL KAREN L sold 682 shares at $110.00 per share on Mar 18. Company shares held by the EVP & Chief Financial Officer now total 34,946.


Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Medtronic plc pays an annual dividend of $2.72, resulting in a dividend yield of 3.49%, and it has a price to earnings (P/E) ratio of 25.64. MDT’s most recent ex-dividend date was 3/23/2023 when it declared a $0.68 quarterly dividend that was paid in cash on 4/14/2023. Previously, the company paid the dividend on 1/13/2023 with an ex-dividend date of 12/20/2022. The MDT stock dividend was $0.68 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for MDT in the last 3 months, the mean price target is $90.49 with high estimates of $127.00 and low estimates of $77.00. In terms of 52-week highs and lows, MDT has a high of $114.31 and a low of $75.76.

As of this writing, MDT has an earnings estimate of $1.27 per share for the current quarter. EPS was calculated based on a consensus of 23 estimates, with a high estimate of $1.32 per share and a lower estimate of $1.25. The company reported an EPS of $1.13 in the last quarter, which was 0.90% higher than expectations of $1.12.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 29 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MDT is Sell with a score of 3.50. A total of 8 analysts rated the stock as Buy while 4 rated it as Overweight while 16 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 1 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles